NanoGhost Overview
NanoGhost is a drug-delivery technology that uses adult stem cells to transport medicine directly to the tumor site. The technology has already proven successful in treating pancreatic, lung, breast, prostate, and brain cancer in mice. The platform is based on nano-vesicles, termed Nano-Ghosts (NGs), which are technologically reconstructed from the cell membranes of naturally targeted allogeneic mesenchymal stem cells (MSCs), after removing their cytoplasm and nuclei. The NGs' safety and targeting capabilities rely on their retention of the surface-associated mechanisms that govern MSCs' well-documented allogeneic tolerability and targeting of multiple inflamed and malignant tissues. The NanoGhost technology was developed by Professor Marcel Machluf, the faculty dean of Biotechnology & Food Engineering at the Technion-Israel Institute of Technology. Professor Machluf developed the technology in her lab at the Technion and set up a start-up as a spin-off from the university to commercialize the technology. Israel's Ministry of Science and Technology named NanoGhost as one of Israel's 60 most impactful developments. The NanoGhost technology has been patented in the United States and Europe, with additional patents pending in India and China.
Cumulative Funding Raised Over Time ($)
Latest News
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $9M |
| Last funding | $4M |
| Stage | Seed |
| Rounds | 2 |
| Investors | 2 |
Team Members
3
Employees: 11-50
Web & Social Links
| Website | www.nano-ghost.com/ |
| Careers | Careers page |
Locations
Beni Ga'on St 12, Netanya, Israel
Photos & Videos
3 item(s)
NanoGhost Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsCore Technology
Materials & SubstancesBiologicalsCellsTags (11)
targeted-cancer-therapycancertargeted-therapystem-cellsdrug-deliverynanotechnologyimmunotherapytreatmentspharmaceuticalsbiotechnologygeneticsGeographic Markets
EuropeIndiaChinaUnited StatesNanoGhost Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
NanoGhost Lifecycle
Cumulative Funding Raised Over Time
All Events
NanoGhost News
7 articlesNanoGhost Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 12 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
NanoGhost Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 90/100 |
| Missing | markets, not claimed |
| BI Verification | Hilla Gorokhovsky |
| Registrar ID | 516071149 |
| Creator | Yotam Maman |
| Creator email | yotamm1988@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-12-04T00:00:00.000Z |
| Created | 2019-12-25T00:00:00.000Z |
| Claimed | Yes |